Orcasho Scientific Solutions · Gastrotrack Control System SYS_TIME 00:00:00

Your gut issues, resolved through enzyme kinetics — not suppressed by one molecule.

We approached the ionic-equilibrium hypothesis trying to falsify it. But every patient cycle behaved like a system returning to its natural set-point — as if the chemistry itself insists the model is correct. Displacing PPIs for GERD, NERD and rGERD, antibiotics for H. Pylori, and bisacodyl for constipation — through a 90-day closed-loop protocol.

Start a consultation Read the model

CH1/CH2 — HCl Capacity vs. Time (Live Sweep)

CH1 — Unmanaged PPI suppression CH2 — Orcasho 90-day regulation

CH1 HCl REMAINING—

CH2 HCl REMAINING—

SWEEP DAY—

SUPPRESSION CONSTANT k0.012

System Architecture

A control layer, not a transactional model.

The entire healthtech and gastro space still operates at a surface-level, transactional model. None of these systems learn. None recalibrate. None converge. They are snapshots, not control layers. Orcasho operates at the systems-engineering layer of biology — running a closed-loop biochemical OS, not a one-time intervention.

CH1 — Industry Model

Drug → Symptom

A single molecule trying to suppress one output of a much deeper dysfunction.

Test → Snapshot

A static report pretending to explain a dynamic biochemical system that changes hourly.

Diet → Guesswork

Generic recommendations without mechanistic grounding or measurable feedback loops.

AI → PDF report

Cosmetic intelligence that analyzes but never intervenes, never adapts, never controls.

CH2 — Orcasho Model

Consultation → Categorisation

Every patient is mapped to a specific gastrotrack disorder profile before anything is prescribed.

Biomarkers → Recalibration

Progress reviewed on day 6, then every 15–20 days, with supplement SETs recalibrated each time.

pH → Enzyme Hydrolysis

Cyclic, non-intrusive supplement combinations modulate gut pH at the right frequency to avoid chemical saturation.

90 days → Stabilisation

The system gets better with the patient, not around them — improving with each cycle rather than repeating it.

GPS NAVIGATION vs AUTOPILOT — Healthcare today sells printed maps. Orcasho is building the autopilot. We are not treating symptoms. We are controlling the system that creates them.

Scope

Over 960 million Indians live with chronic gut issues.

Bloating, constipation, GERD, NERD, acidity, IBS and IBD — our mission is to protect and heal the small intestine, the most affected part of the gut in chronic conditions. Through a structured 12-week program, we regulate gut pH using cyclic, non-intrusive, clinically tested supplements calibrated at the right frequency to restore balance and long-term healing.

90%

Success rate across chronic GERD, rGERD, H. Pylori, villous atrophy and more — even for patients who've tried everything else.

10 → 2

Typical reduction in symptom intensity (out of 10) for IBS / IBD / GERD / H. Pylori over the program.

75%

Of patients report at least this much improvement within the first 40 days of the program.

Diagnostics

Why most existing approaches stop working.

FAULT 01

Chemical saturation

Gastro pharmaceutical medications reach a saturation point and stop working — the body adapts to the molecule, not the other way around.

FAULT 02

Side effects outweigh benefit

These medications often don't work even in early stages, and where they do, side effects — especially to the small intestine — are significant.

FAULT 03

Food maps that don't explain anything

Patients are left wondering what the medication is actually doing, and a generic food map doesn't fit their lifestyle.

FAULT 04

Restrictive diets fail in real life

Strict diet-only alternatives often cause fatigue and are abandoned within two weeks — they don't match how people actually live.

RESOLVED

Orcasho's middle path

Varying supplement calibrations every 15 days, with no dietary restriction — patients keep their lifestyle, which is why retention is high. 90% of gut issues aren't curable but can be maintained: from 10/10 to 2/10, which patients find realistic.

PPI Suppression Model

More PPIs, more suppression, more proton pumps.

This presents simulated data showing the impact of common Proton Pump Inhibitors (PPIs) on the suppression of hydrochloric acid (HCl) in the human stomach over time. The graphs are based on pharmacokinetic decay models which predict the intensity of acid suppression with varying doses and durations. More PPIs mean a higher acid-suppression percentage — which, in turn, drives overproduction of new proton pumps.

HCl Suppression — Exponential Decay Equation

HCl_t = 100 × e^{(−k × t)}

HCl_t — acid capacity remaining at day t, as a percentage of baseline · k — suppression constant, varies by drug and dose · t — number of days of continuous PPI usage

CH3 — Regimen Sweep (Auto-Cycling)

Pantoprazole 40mg OD

HCl REMAINING—

SUPPRESSION CONSTANT k—

PUMP OVEREXPRESSION—

SWEEP DAY / MAX—

Consequences

Side effects of long-term acid suppression.

Core Effects

Vitamin B12 deficiency — loss of intrinsic factor activation

Magnesium deficiency — impaired absorption

Increased risk of gut infections, e.g. C. difficile

Rebound acid hypersecretion after withdrawal

Disrupted protein digestion, poor nutrient extraction

Expanded Long-Term Effects

Calcium malabsorption — osteoporosis, fractures

Iron deficiency anaemia (low-acid environment)

Chronic kidney disease, acute interstitial nephritis

Liver enzyme alterations with long-term use

Increased risk of community-acquired pneumonia

Gastric polyps and fundic gland hyperplasia

Elevated dementia risk in elderly (correlative)

Disruption of gut microbiota (dysbiosis)

Elevated homocysteine from B12 deficiency

Impaired zinc and selenium absorption

Fat malabsorption from altered bile acids

Potential masking of early-stage gastric cancers

Balanced acid = balanced enzyme hydrolysis for digestion. This is how pH variation accelerates or limits the kinetic function of digestive enzymes — and why our supplement SETs are recalibrated every 15 days based on the pH values of the supplements themselves, to reduce IBS / IBD / GERD / H. Pylori from 10/10 to 2/10.

pH & Ionic Balance

How our program brings you back to normal.

The cascades below run continuously — the left channel shows disrupted digestion at its starting point; the right channel shows the same chemistry once the 90-day protocol takes effect.

CH1 — Starting Point: Disrupted Digestion

Inflammation + oxidative stress (ROS)

ATP ↓ → Na⁺/K⁺-ATPase ↓

Cl⁻ & HCO₃⁻ secretion ↓ → H₂O movement ↓

Vagal tone ↓ → LES tone ↓

Mucus ↓ + Buffering ↓ → acid damage

Gastric pH ↑ (too weak) or volume ↑ (overload) → impaired enzyme hydrolysis

Pancreatic enzyme imbalance + bile stagnation → ↓ nutrient absorption

OUTPUT: hard stool, acid reflux, bloating, pain, mucosal erosion, fermentation & gas, inflammation.

CH2 — 90-Day Protocol: Normal Digestion State

Phase 1 — Antioxidant + mitochondrial support ↑

ATP ↑ → Na⁺/K⁺-ATPase ↑

Cl⁻ & HCO₃⁻ secretion ↑ → H₂O movement ↑ → stool softening

Phase 2 — Inflammation ↓ → Vagal tone ↑ → LES tone ↑

Gastric pH normalisation (1.5–3.0) → enzyme hydrolysis efficiency ↑

Phase 3 — Mucosal healing ↑ + HCO₃⁻ buffering ↑ → epithelial protection ↑

Bile flow ↑ + pancreatic enzyme activation ↑ → nutrient absorption ↑

Phase 4 — Hormonal resilience ↑ + gut-brain axis homeostasis + peristalsis ↑

OUTPUT: soft stool, no acid backflow, no pain or inflammation, clean digestion, full nutrient absorption, long-term relief.

Phase 1 · Days 1–22

Energy Reset

Antioxidant and mitochondrial support increases ATP availability, driving Na⁺/K⁺-ATPase activity, bicarbonate secretion, and water movement — softening stool and restoring baseline hydration.

Phase 2 · Days 23–45

Neural & Acid Control

Reduced inflammation raises vagal tone and LES tone, lowering reflux. Gastric pH normalises toward 1.5–3.0, improving enzyme hydrolysis and complete protein/fat breakdown.

Phase 3 · Days 46–90

Barrier & Digestive Support

Mucosal healing and bicarbonate buffering increase, neutralising acid and protecting the epithelium. Bile flow and pancreatic enzyme activation rise.

Phase 4 · Post 90 Days

Hormone & Motility Lock-In

Consecutive cycles build hormonal resilience and gut-brain axis regulation — peristalsis improves and relief becomes long-term.

GERD & The Sphincter

Ionic and biochemical pathway analysis.

Gastroesophageal reflux disease (GERD) occurs when the lower esophageal sphincter (LES) weakens, allowing stomach acid (HCl) to backflow into the esophagus. This breakdown is not purely mechanical — it involves a complex interplay of ionic, muscular, and pH-regulating pathways.

CH4 — Ionic Reaction: HCl vs Magnesium (looping)

01HCl → H⁺ + Cl⁻

02Cl⁻ + Mg²⁺ (local ionic pool) → MgCl₂ (inactive binding)

03Mg²⁺ depletion from tissue → impaired LES muscle contraction

LES Muscle Tone — Push/Pull Mechanism

Mg²⁺ → contraction (myosin ATPase) | Ca²⁺ → relaxation

This push–pull mechanism maintains LES closure strength. Chronic Mg²⁺ depletion results in uncoordinated muscle contraction and incomplete closure — even though oral magnesium supplements often fail to fix this, since poor stomach acid quality limits Mg²⁺ absorption and may cause osmotic imbalance or loose stools.

The Role of PPIs

How Proton Pump Inhibitors act on the system.

PPI Structure — Omeprazole (substituted benzimidazole)

C₁₇H₁₉N₃O₃S

PPI + H⁺/K⁺-ATPase (gastric parietal cell) → inhibition of acid secretion → reduced acid → reduced Mg²⁺ absorption in the small intestine → long-term use → LES weakening via ionic depletion and neuromuscular downregulation.

Renal Impact

↓ Mg²⁺ absorption

↑ Renal Mg²⁺ excretion

Distal tubular acidosis risk

Long-term PPI use is linked to hypomagnesemia, leading to tubular dysfunction.

Hepatic Impact

PPI + CYP3A4 inhibition

↓ Phase I/II biotransformation

Toxin backlog

PPIs alter hepatic cytochrome P450 function — elevated ALT/AST, sluggish bile flow, increased hepatic steatosis risk.

Beyond acid suppression, by neutralising gastric acid, PPIs also reduce the acidic chyme entering the small intestine, delay or impair the release of pancreatic enzymes (lipase, amylase, trypsin), disrupt bile acid emulsification of fats, and impair absorption of minerals and cofactors required for enzyme activation. LES dysfunction in GERD is therefore not simply mechanical — it's biochemical. By targeting acid pH, volume, and supporting the body's natural magnesium economy via liver storage and kidney reabsorption, long-term structural recovery of the sphincter is possible. Our protocol helps displace PPIs nearly 100% over time by re-establishing natural proton pump rhythm, maintaining intestinal pH gradients, and enabling full systemic biochemical adaptation — without dietary restriction.

Medication Efficiency + pH Regulation

How our program enhances medication absorption.

Your gut, when supported with mucosal healing and pH regulation, allows better bioconversion of medications — meaning less medication is needed for the same effect, with fewer side effects. Our protocol doesn't restrict diet; it enhances internal chemistry so you absorb and regulate better.

Without Gut Optimization

Medication (5 mg)

Absorption ↓ (~10%)

Active Dose: 0.5 mg

0.5 mg active

Gut pH imbalance → incomplete digestion + residual inflammation → side effects ↑

With Gut Optimization — My Happy Gut

Med (5 mg) + Enzyme Activity ↑ + Mucosal Repair ↑ + pH Buffering ↑

Absorption ↑ (~50%)

Active Dose: 2.5 mg

2.5 mg active

Dose/frequency ↓ + side effects ↓ + gut lining integrity ↑

Beyond Digestion

Small intestine health, fertility, and pregnancy.

Optimising villi function in the small intestine improves absorption of zinc, magnesium, iron, folate and B12 — nutrients directly tied to hormone synthesis (FSH, LH, estrogen, progesterone), menstrual regularity, ovulation quality, and pregnancy outcomes including implantation, placental health, and fetal growth. As reported by patients preparing for pregnancy, the same pH and enzyme groundwork that resolves gut symptoms also supports reproductive health.

CH5 — Nutrient Pathway: Intestine → Reproductive Outcomes (running)

Small Intestine

Zn, Mg, Fe, Folate, B12
Na⁺ K⁺ Mg²⁺ Zn²⁺ Fe²⁺

Blood Vessel

Plasma nutrient transport
Hormone precursor delivery

Menstrual Cycle

FSH, LH, estrogen, progesterone
Endometriosis, genital tract health

Gamete Formation

Ovarian function, egg quality
PCOS, fertility

Fertilization

Embryo development
IVF outcome

Placentation

Adverse pregnancy outcome risk

Fetal Growth

Live birth rates
Infant gut microbiome

Nutrient absorption in the small intestine is the upstream input for every downstream stage of the reproductive pathway — from menstrual regularity through to infant gut microbiome at birth.

MENSTRUAL

Hormone synthesis support

Increases plasma nutrient levels to support FSH, LH, estrogen, progesterone — promoting regular cycles, reducing menstrual pain and heavy bleeding via magnesium (relaxes uterine muscles) and iron (prevents anemia). Folate and B12 improve period quality, reducing fatigue.

FERTILITY

Ovarian function and egg quality

Zinc and magnesium absorption enhances ovarian function and egg quality, supports ovulation timing and gamete health, and reduces inflammation from PCOS or endometriosis — improving uterine receptivity.

PREGNANCY

Implantation through fetal growth

Nutrient-rich blood supply enhances embryo development and implantation, improves placental health, reduces preeclampsia risk, and promotes healthy fetal growth, higher live birth rates, and proper pregnancy spacing and structural fetal development.

Clinical Evidence

The dataset behind the model.

Dynamic Biochemical Compounding (DBC)

Orcasho's DBC system redefines gut health management by treating the digestive system as an adaptive biochemical reactor. Unlike static supplements (e.g. Viome, Seed), which lose efficacy due to tolerance buildup, our AI-driven, 20-day rotating protocols target ionic imbalances (Na⁺, K⁺, Cl⁻, H⁺) to resolve chronic disorders like GERD, constipation, and bloating. Our 3-layer therapeutic system, proprietary IP, and patient-centric design create an uncopyable moat in the $51.62B gut health market.

FIG 1 — GDS Scores Before & After Treatment, 14 Patients

Current GDS (baseline) Improved GDS (90% relief target)

TABLE 1 — GDS & GIS for 14 Patients

Patient	Current GDS	Improved GDS	Current GIS	Improved GIS	Other Improvements
Patient 1	75	7.5	80	8.0	Microbiome diversity up 90%; pathogens reduced; Rych Index 4.8 ↔ 9.5.
Patient 2	65	6.5	70	7.0	ESR 30 ↔ 5; CRP 2.3 ↔ 0.5; SGPT 46 ↔ 20; ALP 140 ↔ 70.
Patient 3	50	5.0	55	5.5	Triglycerides 182 ↔ 100; GGT 38 ↔ 10; Vit B12 203 ↔ 500.
Patient 4	60	6.0	65	6.5	HbA1c 5.7 ↔ 4.5; ALP 138 ↔ 70; ESR 70 ↔ 7.
Patient 5	55	5.5	60	6.0	Platelets 78 ↔ 300.
Patient 6	45	4.5	50	5.0	Vit B12 203 ↔ 500; Ferritin 11.9 ↔ 100.
Patient 7	70	7.0	75	7.5	H. pylori negative.
Patient 8	80	8.0	85	8.5	Esophagitis / pangastritis resolved.
Patient 9	55	5.5	60	6.0	Vit B12 115 ↔ 300; Iron 12 ↔ 100.
Patient 10	65	6.5	70	7.0	Fecal Elastase 33.79 ↔ 450.
Patient 11	50	5.0	55	5.5	Vit D 17.41 ↔ 50; SGPT 58.2 ↔ 20.
Patient 12	60	6.0	65	6.5	Esophagitis / CT air pocket resolved.
Patient 13	70	7.0	75	7.5	ESR 70 ↔ 7; CRP 5.9 ↔ 0.5; HbA1c 6.9 ↔ 5.0.
Patient 14	70	7.0	75	7.5	Hemoglobin 9.5 ↔ 13.5; Iron 30.4 ↔ 100; ESR 28 ↔ 5; Albumin 4.0 ↔ 4.5; TSH normalised.

GDS = Gut Disorder Score · GIS = General Inflammation Score — scaled out of 100. "Improved" = 90% relief target under protocol.

FIG 2 — Clinical Intensity: PPI Usage, GDS & GIS Averages

Baseline After 90 Days

PPI dependency and gut/general disorder severity (GDS/GIS) both collapse toward single-digit levels after 90 days — while baseline scores across the 14-patient cohort cluster in the 45–85 range.

FIG 4 — Patient A's Symptom Scores Over Treatment Cycles (auto-advancing)

GERD Constipation Bloating

CYCLEInitial

GERD4.0

Constipation3.0

Bloating2.0

My Happy Gut

A 12-week, 5-step program.

Covering Constipation / IBS-C, IBD, GERD / NERD / rGERD, and H. Pylori. No dependency on restrictive diets — just 2 to 5 minutes a day, targeting the chemical cause: poor hydrolysis, faulty acid production, and weak enzyme flow.

STEP 01

Consultation & categorisation

We assess your case and categorise it into a specific gastrotrack disease or disorder type.

STEP 02

Program purchase

The 90-day program is purchased based on your categorisation and case complexity.

STEP 03

Supplement allocation

We allocate a specific supplement SET for your gastrotrack issue from the first cycle, free of charge.

STEP 04

Shipping

Supplements are sourced from established FSSAI-licensed manufacturers — Carbamide Forte, Healthy Hey, Viteva Organic, Nutriherbs, Merlion and Inlife — and shipped sealed.

STEP 05

Biomarker check-ins & recalibration

We review progress on day 6, then every 15–20 days across the 90 days, recalibrating your SET after each consultation to avoid chemical saturation.

Team Orcasho

A combined functional effort.

All directions in the treatment are a combined functional effort of the team — clinicians, researchers, and specialists working from the same biochemical model.

Vikrant Mahesh

Founder & CEO

European Union Researcher · Marie Skłodowska-Curie Fellow (Fundamental Chemistry)

Dr. Balaji Gurappa

Advisory Board Member

MBBS & MD — General Medicine · DM — Gastroenterology

Navya Bharti

Chief Nutrition Specialist

PG Diploma in Nutrition & Dietetics · Life Member, Indian Dietetic Association

Dr. Bhavana G Naik

Chief Medical Doctor

MBBS · Certified Telehealth Practitioner (TSI) · AJ Institute of Medical Sciences, Mangalore

Dr. Satish

Radiologist

MBBS, MD (Radiology) · 10+ years in Diagnostic Radiology

Dr. Sneha Patil

Community Medicine

MBBS, Indira Gandhi Government College · MD, Community Medicine

Dr. Sahar Shuja Khan Ghori

Psychiatry

MBBS, JSS Medical College & Hospital, Mysore · MD Psychiatry, Meenakshi Medical College

Dr. Nisha Dhiman

Prescribing Physician

BHMS, DNHE · Gold Medalist, Panjab University

Dr. Pallavi HB

Yoga & Wellness

BE, MTech, PhD (ML) · Internationally Certified Yoga Teacher, Bhodi Yoga Academy / Ministry of Ayush

Dr. Aarshika Singh

Obstetrics & Gynaecology

MBBS, MS (OBG), Jawaharlal Nehru Medical College, Wardha

Protocol Procedure

What the program cost actually covers.

The cost of the program is for the consultations + supplement calibration over the course of 3 months. The first set of supplements is free in the first cycle, and we calibrate these supplements as per your case every 10 or 15 days after your consultations — so it is not a "box solution".

By the end of the 12-week program, some supplements might be remaining for a few patients.

During the course of the program, we use more of some supplements than others — in this case it is required for the patient to buy the additional supplements until the 12-week program is complete.

If a patient misses a consultation during the 3 months, the 90-day period will not be extended with respect to consultations or any supplement-related calibrations. The efficacy of the treatment will be affected.

We do not manufacture the supplements — we source them from well-known manufacturers such as Carbamide Forte, Healthy Hey, Viteva Organic, Nutriherbs, Merlion and Inlife. All supplements provided are procured from FSSAI-licensed manufacturers and shipped in original sealed form. Orcasho does not manufacture, relabel, or repackage any food or dietary product, or store it in inventory.

Our program is directed towards treating non-curable gastrotrack diseases by displacing pharmaceutical medications and replacing them with our treatment. So if required, depending on the case, it may be necessary to continue our program every quarter for the positive results of the treatment to be maintained. If the results are not satisfactory, the patient can stop the program after the first quarter.

Following point 5, we will explain how we can help with your condition in detail, and it is up to the customer to go ahead with the program or not — but we will not be responsible for any false claims or provide any refunds.

All the above points apply once the purchase of the program is complete. For more information, please go through the "Privacy Policy & Terms and Conditions" at the end of the website.

Any variation in the 3-month protocol — such as and not limited to points A, B, C, D and E — will immediately be considered as failure to follow the protocol:

ANot following the exact number, frequency and supplement count in the given combination.

BGiving breaks in between without informing us 72 hours before.

CFailing to provide proof-of-purchase evidence of additional required supplements during the program.

DFailure to let us know 7 days beforehand if a given supplement is getting close to a low count.

EFailure to follow the food intake timings provided by us during the course of the program.

Claiming that the website was not provided will not be accepted, as it is the first thing we provide when you get in touch with us — whether an advert is clicked or by direct contact. In any case, it is up to the individual to go through the website before the start of the protocol.

All directions in the treatment are a combined functional effort of the team.

Reality of Relapse

"Relapse" doesn't apply the way you think it does.

With respect to gastrotrack systems, the system is dominated by enzymes, and their pH states are varied by interventions such as post-surgeries, food habits and timings, stress, sleep patterns, past and present medication history (including medications for cholesterol, diabetes, antidepressants, thyroid, painkillers, blood thinners), age, and gastromedications such as PPIs, H2 blockers, and antibiotics. Irrespective of our treatment or not, this is applicable for everyone.

Route 2A

Gastro pharma medications

Side effects and lack of efficacy over time.

Route 2B

Extreme restrictive diet, no pharma

Impractical and leads to fatigue over time.

Route 2C — Orcasho

90% supplementation (natural) + 10% diet control

These three points are the only options in the industry, and our treatment (2C) is growing in favouritism as it's the middle path.

The term "relapse" cannot be applied to any multichronic gastrotract issue — the gastrotrack is dominated by enzymes only, and it is not like other muscle tissue, bones, heart, liver or kidney, which are separate units (to put it simply). Depending on the variability described above, treatment has to be constantly adapted to each situation — for each case we do the same, using various combinations of supplements, and the same applies to any human.

What outcomes we've noticed in our treatments.

If the variabilities are consistent with the factors above, patients continue our treatment and we keep adapting to those variabilities — finding the best possible combination each time to stabilise the situation. We have had people on the treatment for over 12 to 15 months.

If the variabilities are low (around 1/10), patients do our treatment for 2 cycles (6 months) maximum. We find the most suitable set and advise them to continue with these combinations — unless they fall under too much variation as described above.

3A and 3B are the possible outcomes from our treatment. If a patient is not comfortable with either, then 2A and 2B are the only other options. We are not aware of any other treatment that reaches perfection and no relapse in reality with respect to gastrotrack issues.

Reference

Biochemical abbreviations.

Symbol	Full Form	Explanation
ATP	Adenosine Triphosphate	Main energy currency of the cell; powers ion pumps and active transport.
ROS	Reactive Oxygen Species	Damaging free radicals produced during inflammation and oxidative stress.
Na⁺/K⁺-ATPase	Sodium–Potassium Pump	Membrane-bound enzyme moving Na⁺ out and K⁺ into cells using ATP; drives water balance and ion exchange.
Cl⁻	Chloride Ion	Draws water into the intestinal lumen for soft stool; supports acid/base balance.
HCO₃⁻	Bicarbonate Ion	A base that neutralizes excess acid in the stomach and gut; protects the mucosa.
H₂O	Water	Follows salts osmotically; needed for stool hydration and enzyme activity.
LES	Lower Esophageal Sphincter	Muscle valve between esophagus and stomach; prevents acid reflux.
GERD	Gastroesophageal Reflux Disease	Condition where stomach acid frequently backs up into the esophagus.
pH	Potential of Hydrogen	Scale from 0–14 measuring acidity/alkalinity; optimal stomach pH for digestion is ~1.5–3.0.
H⁺	Hydrogen Ion	Helps emulsify fats for absorption in the small intestine.
Mg²⁺	Magnesium Ion	Required for LES muscle contraction via myosin ATPase activation; chronically depleted by reflux.
Ca²⁺	Calcium Ion	Required for LES muscle relaxation; works opposite Mg²⁺ in the push–pull tone mechanism.
NERD	Non-Erosive Reflux Disease	Chronic GERD symptoms with no physical indentation visible on endoscopy.
rGERD	Refractory GERD	Chronic GERD symptoms persisting even with frequent daily PPI use.
CYP3A4	Cytochrome P450 3A4	Liver enzyme responsible for Phase I drug metabolism; inhibited by long-term PPI use.

Clarity

Frequently asked questions.

How long is the program?

It always starts at 3 months — we don't offer 1-month, 15-day, or 1-week trials. Gastrotrack issues adapt to a new digestion routine over time, which requires changing the supplement combination as the cycle progresses.

Can gastrotrack issues be cured?

"Cure" applies to a disease — gastrotrack issues are disorders, and can be reduced in intensity and maintained, not eliminated permanently.

What happens after 3 months?

We continue into following quarters, strengthening the digestion cycle habituation and reducing chronic intensity further, using new supplement combinations built on the best-suited set from the first quarter.

How does it all end?

Some patients stay on the program over 12 months because it lets them live without dietary restriction, while also seeing improvements in diabetic, cholesterol and thyroid levels, skin, sleep, stress and joint pain. By the third quarter, supplement frequency drops — but some ongoing support is generally needed to maintain gastrotrack efficiency long-term.

Does it interfere with other medications?

No. The program is designed to work alongside existing medications while gradually improving how effectively the body absorbs and uses them.

What if I'm an anxiety patient?

We take this seriously — anxiety patients are advised to continue medication prescribed by a psychiatrist, and we can connect you with the psychiatrist on our team. Anxiety can make gut issues worse, and any treatment needs time to work.

Does sleep play a role?

Yes — we recommend 8 hours, ideally between 10pm and 6am. Roughly 70% of gut issues are linked to insufficient sleep.

Does stress or exercise play a role?

Stress: yes, to a meaningful degree (around 20%). Exercise: a smaller factor (around 10%), but still relevant.

What type of patients do you usually treat?

Around 60% are currently on gastro-pharma medication, 30% have saturated on it with diminishing results, and 10% come to us before trying any gastro-pharma medication at all.

How soon can we see results?

Typically 3 to 9 months depending on age, number of issues, and chronicity. 85% of patients report at least 75% improvement within the first 40 days.

Can people without gut issues join?

Yes — and it's the ideal time to start. Building biochemical barriers, ATP generation, mucosal lining and small intestine hydrolysis before stress or lifestyle imbalances cause damage means you may never hit a gut issue at all.

Who should not join the program?

Anyone who hasn't understood the answers above — the program depends on a clear understanding of how it works and what to expect.

Get In Touch

Tried everything for your gut? Try us first.

Our My Happy Gut program delivers results even before patients resort to mainstream drugs — including chronic GERD, rGERD, H. Pylori, and villous atrophy. We also support recovery from gut damage caused by steroids, thyroid medication, antidepressants, diabetes medication and antibiotics.

WhatsAppMessage Orcasho directly

Emailinfo@orcasho.com

Orcasho Scientific Solutions Pvt. Ltd.

BEML Layout, 3rd Floor, 3rd Stage, Halage Vaderahalli, RR Nagar, Bangalore – 560098

All supplements are procured from FSSAI-licensed manufacturers and shipped in original sealed form. Orcasho does not manufacture, relabel, or repackage any food or dietary product, nor does it hold inventory.

WhatsApp QR code for Orcasho Scientific Solutions

Scan to start a WhatsApp chat with Orcasho Scientific Solutions Private Limited.